Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015 (2015), Article ID 320532, 7 pages
http://dx.doi.org/10.1155/2015/320532
Review Article

Virological Mechanisms in the Coinfection between HIV and HCV

1Department of Health Sciences, Institute of Microbiology, School of Medicine, University of “Magna Graecia”, Viale Europa, Germaneto, 88100 Catanzaro, Italy
2Department of Medical and Surgical Sciences, Unit of Infectious and Tropical Diseases, School of Medicine, University of “Magna Graecia”, Viale Europa, Germaneto, 88100 Catanzaro, Italy

Received 12 June 2015; Revised 1 September 2015; Accepted 7 September 2015

Academic Editor: Hirayuki Enomoto

Copyright © 2015 Maria Carla Liberto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Y. Kim and R. T. Chung, “Coinfection with HIV-1 and HCV—A one-two punch,” Gastroenterology, vol. 137, no. 3, pp. 795–814, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Y. Chen, E. R. Feeney, and R. T. Chung, “HCV and HIV co-infection: mechanisms and management,” Nature Reviews Gastroenterology and Hepatology, vol. 11, no. 6, pp. 362–371, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Sengupta, E. Powell, L. Kong, and J. T. Blackard, “Effects of HCV on basal and Tat-induced HIV LTR activation,” PLoS ONE, vol. 8, no. 6, Article ID e64956, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Kong, W. C. Maya, M. E. Moreno-Fernandez et al., “Low-level HIV infection of hepatocytes,” Virology Journal, vol. 9, article 157, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. W. Ansari, R. E. Schmidt, E. M. Shankar, and A. Kamarulzaman, “Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus,” Journal of Translational Medicine, vol. 12, article 341, 2014. View at Publisher · View at Google Scholar
  6. C. M. Mastroianni, M. Lichtner, C. Mascia, P. Zuccalà, and V. Vullo, “Molecular mechanisms of liver fibrosis in HIV/HCV coinfection,” International Journal of Molecular Sciences, vol. 15, no. 6, pp. 9184–9208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Lin, E. M. Weinberg, and R. T. Chung, “Pathogenesis of accelerated fibrosis in HIV/HCV co-infection,” Journal of Infectious Diseases, vol. 207, supplement 1, pp. S13–S18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. S. L. Friedman, “Mechanisms of hepatic fibrogenesis,” Gastroenterology, vol. 134, no. 6, pp. 1655–1669, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Bruno, S. Galastri, P. Sacchi et al., “gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis,” Gut, vol. 59, no. 4, pp. 513–520, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Lin, E. M. Weinberg, A. W. Tai et al., “HIV increases HCV replication in a TGF-beta1-dependent manner,” Gastroenterology, vol. 134, no. 3, pp. 803–811, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Lin, W.-L. Tsai, R.-X. Shao et al., “Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner,” Gastroenterology, vol. 138, no. 7, pp. 2509.e1–2518.e1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Swaminathan, D. Pascual, G. Rival, R. Perales-Linares, J. Martin-Garcia, and S. Navas-Martin, “Hepatitis C virus core protein enhances HIV-1 replication in human macrophages through TLR2, JNK, and MEK1/2-dependent upregulation of TNF-α and IL-6,” FEBS Letters, vol. 588, no. 18, pp. 3501–3510, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. C. G. Tsiara, G. K. Nikolopoulos, N. L. Dimou et al., “Effect of hepatitis C virus on immunological and virological responses in HIV-infected patients initiating highly active antiretroviral therapy: a meta-analysis,” Journal of Viral Hepatitis, vol. 20, no. 10, pp. 715–724, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Gale Jr. and E. M. Foy, “Evasion of intracellular host defence by hepatitis C virus,” Nature, vol. 436, no. 7053, pp. 939–945, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. D. R. Yang and H. Z. Zhu, “Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?” World Journal of Gastroenterology, vol. 21, no. 13, pp. 3786–3800, 2015. View at Publisher · View at Google Scholar
  16. V. D. Gonzalez, A. L. Landay, and J. K. Sandberg, “Innate immunity and chronic immune activation in HCV/HIV-1 co-infection,” Clinical Immunology, vol. 135, no. 1, pp. 12–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Gerosa, B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri, “Reciprocal activating interaction between natural killer cells and dendritic cells,” Journal of Experimental Medicine, vol. 195, no. 3, pp. 327–333, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. N. J. Megjugorac, H. A. Young, S. B. Amrute, S. L. Olshalsky, and P. Fitzgerald-Bocarsly, “Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells,” Journal of Leukocyte Biology, vol. 75, no. 3, pp. 504–514, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. I. R. Sianipar, C. Matsui, N. Minami et al., “Physical and functional interaction between hepatitis C virus NS5A protein and ovarian tumor protein deubiquitinase 7B,” Microbiology and Immunology, vol. 59, no. 8, pp. 466–476, 2015. View at Publisher · View at Google Scholar
  20. H. Dansako, M. Ikeda, and N. Kato, “Limited suppression of the interferon-β production by hepatitis C virus serine protease in cultured human hepatocytes,” The FEBS Journal, vol. 274, no. 16, pp. 4161–4176, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Falson, B. Bartosch, K. Alsaleh et al., “Hepatitis C virus envelope glycoprotein E1 forms trimers at the surface of the virion,” Journal of Virology, 2015. View at Publisher · View at Google Scholar
  22. J. Xiang, C. Martinez-Smith, M. Gale Jr. et al., “GB virus type C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF2alpha phosphorylation,” Journal of Interferon and Cytokine Research, vol. 25, no. 5, pp. 261–270, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. Chattergoon, R. Latanich, J. Quinn et al., “HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1,” PLoS Pathogens, vol. 10, no. 5, Article ID e1004082, 2014. View at Publisher · View at Google Scholar
  24. C. H. Yoon, S. Y. Kim, S. E. Byeon et al., “p53-derived host restriction of HIV-1 replication by protein kinase R-mediated tat phosphorylation and inactivation,” Journal of Virology, vol. 89, no. 8, pp. 4262–4280, 2015. View at Publisher · View at Google Scholar
  25. A. Glässner, M. Eisenhardt, P. Kokordelis et al., “Impaired CD4+ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients,” Journal of Hepatology, vol. 59, no. 3, pp. 427–433, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Z. Mehal and S. L. Friedman, “The role of inflammation and immunity in the pathogenesis of liver fibrosis,” in Liver Immunology, pp. 111–121, Humana Press, Clifton, NJ, USA, 2007. View at Publisher · View at Google Scholar
  27. C.-T. K. Tseng and G. R. Klimpel, “Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions,” Journal of Experimental Medicine, vol. 195, no. 1, pp. 43–50, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. S. R. Vlahakis, A. Villasis-Keever, T. S. Gomez, G. D. Bren, and C. V. Paya, “Human immunodeficiency virus-induced apoptosis of human hepatocytes via CXCR4,” Journal of Infectious Diseases, vol. 188, no. 10, pp. 1455–1460, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Munshi, A. Balasubramanian, M. Koziel, R. K. Ganju, and J. E. Groopman, “Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism,” Journal of Infectious Diseases, vol. 188, no. 8, pp. 1192–1204, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Balasubramanian, R. K. Ganju, and J. E. Groopman, “Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes,” Journal of Infectious Diseases, vol. 194, no. 5, pp. 670–681, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Rotman and T. J. Liang, “Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes,” Journal of Virology, vol. 83, no. 15, pp. 7366–7374, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Zhang, B. Saha, K. Kodys, and G. Szabo, “IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells,” Journal of Hepatology, vol. 59, no. 3, pp. 442–449, 2013. View at Publisher · View at Google Scholar
  33. H. Saïdi, M.-T. Melki, and M.-L. Gougeon, “HMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talk,” PLoS ONE, vol. 3, no. 10, Article ID e3601, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. I.-W. Park, Y. Fan, X. Luo et al., “HIV-1 Nef is transferred from expressing T cells to hepatocytic cells through conduits and enhances HCV replication,” PLoS ONE, vol. 9, no. 6, Article ID e99545, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Qu, Q. Zhang, Y. Li et al., “The Tat protein of human immunodeficiency virus-1 enhances hepatitis C virus replication through interferon gamma-inducible protein-10,” BMC Immunology, vol. 13, article 15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Kang, Z. Luo, Y. Li et al., “Association of Vpu with hepatitis C virus NS3/4A stimulates transcription of type 1 human immunodeficiency virus,” Virus Research, vol. 163, no. 1, pp. 74–81, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Deng, C. Chen, Y. Ishizaka, X. Chen, B. Sun, and R. Yang, “Human immunodeficiency virus type 1 Vpr increases hepatitis C virus RNA replication in cell culture,” Virus Research, vol. 184, pp. 93–102, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Balasubramanian, R. K. Ganju, and J. E. Groopman, “Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes,” The Journal of Biological Chemistry, vol. 278, no. 37, pp. 35755–35766, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. K. E. Yoong, S. C. Afford, R. Jones et al., “Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by γ-interferon in lymphocyte recruitment to hepatocellular carcinoma,” Hepatology, vol. 30, no. 1, pp. 100–111, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Bonacini, S. Louie, N. Bzowej, and A. R. Wohl, “Survival in patients with HIV infection and viral hepatitis B or C: a cohort study,” AIDS, vol. 18, no. 15, pp. 2039–2045, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Qu, Z. Yang, Q. Zhang et al., “Human immunodeficiency virus-1 Rev protein activates hepatitis C virus gene expression by directly targeting the HCV 5′-untranslated region,” FEBS Letters, vol. 585, no. 24, pp. 4002–4009, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. D. M. D'Agostino, B. K. Felber, J. E. Harrison, and G. N. Pavlakis, “The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs,” Molecular and Cellular Biology, vol. 12, no. 3, pp. 1375–1386, 1992. View at Google Scholar · View at Scopus
  43. A. I. Dayton, J. G. Sodroski, C. A. Rosen, W. C. Goh, and W. A. Haseltine, “The trans-activator gene of the human T cell lymphotropic virus type III is required for replication,” Cell, vol. 44, no. 6, pp. 941–947, 1986. View at Publisher · View at Google Scholar · View at Scopus
  44. M. R. Stettner, J. A. Nance, C. A. Wright et al., “SMAD proteins of oligodendroglial cells regulate transcription of JC virus early and late genes coordinately with the Tat protein of human immunodeficiency virus type 1,” Journal of General Virology, vol. 90, no. 8, pp. 2005–2014, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Nyagol, E. Leucci, A. Onnis et al., “The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis,” Cancer Biology and Therapy, vol. 5, no. 6, pp. 684–690, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Huang, I. Bosch, W. Hofmann, J. Sodroski, and A. B. Pardee, “Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains,” Journal of Virology, vol. 72, no. 11, pp. 8952–8960, 1998. View at Google Scholar · View at Scopus
  47. A. I. Romero, M. Lagging, J. Westin et al., “Interferon (IFN)-γ-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-α 2a and ribavirin for chronic hepatitis C virus infection,” Journal of Infectious Diseases, vol. 194, no. 7, pp. 895–903, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. A. M. Joseph, M. Kumar, and D. Mitra, “Nef: ‘necessary and enforcing factor’ in HIV infection,” Current HIV Research, vol. 3, no. 1, pp. 87–94, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. M. I. Thoulouze, N. Sol-Foulon, F. Blanchet, A. Dautry-Varsat, O. Schwartz, and A. Alcover, “Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse,” Immunity, vol. 24, no. 5, pp. 547–561, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Nobile, D. Rudnicka, M. Hasan et al., “HIV-1 Nef inhibits ruffles, induces filopodia, and modulates migration of infected lymphocytes,” Journal of Virology, vol. 84, no. 5, pp. 2282–2293, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. A. V. Ivanov, B. Bartosch, O. A. Smirnova, M. G. Isaguliants, and S. N. Kochetkov, “HCV and oxidative stress in the liver,” Viruses, vol. 5, no. 2, pp. 439–469, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Ming-Ju, H. Yih-Shou, C. Tzy-Yen, and C. Hui-Ling, “Hepatitis C virus E2 protein induce reactive oxygen species (ROS)-related fibrogenesis in the HSC-T6 hepatic stellate cell line,” Journal of Cellular Biochemistry, vol. 112, no. 1, pp. 233–243, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. F. J. Cubero and N. Nieto, “Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor α, reduced glutathione, and transforming growth factor β–dependent mechanisms,” Hepatology, vol. 48, no. 6, pp. 2027–2039, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Kogan and J. Rappaport, “HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention,” Retrovirology, vol. 8, article 25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Peng, X. Xiao, Y. He et al., “HIV Vpr protein upregulates microRNA-122 expression and stimulates hepatitis C virus replication,” Journal of General Virology, vol. 96, no. 8, pp. 2453–2463, 2015. View at Publisher · View at Google Scholar
  56. K. D. Conrad, F. Giering, C. Erfurth et al., “MicroRNA-122 dependent binding of Ago2 protein to hepatitis C virus RNA is associated with enhanced RNA stability and translation stimulation,” PLoS ONE, vol. 8, no. 2, Article ID e56272, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. J. I. Henke, D. Goergen, J. Zheng et al., “microRNA-122 stimulates translation of hepatitis C virus RNA,” The EMBO Journal, vol. 27, no. 24, pp. 3300–3310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Shimakami, D. Yamane, R. K. Jangra et al., “Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 3, pp. 941–946, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. W. C. Goh, M. E. Rogel, C. Matthew Kinsey et al., “HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo,” Nature Medicine, vol. 4, no. 1, pp. 65–71, 1998. View at Publisher · View at Google Scholar · View at Scopus
  60. B. Poon, K. Grovit-Ferbas, S. A. Stewart, and I. S. Y. Chen, “Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents,” Science, vol. 281, no. 5374, pp. 266–269, 1998. View at Publisher · View at Google Scholar · View at Scopus
  61. P. Simmonds, “The origin of hepatitis C virus,” Current Topics in Microbiology and Immunology, vol. 369, pp. 1–15, 2013. View at Publisher · View at Google Scholar
  62. C.-L. Tai, W.-K. Chi, D.-S. Chen, and L.-H. Hwang, “The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3),” Journal of Virology, vol. 70, no. 12, pp. 8477–8484, 1996. View at Google Scholar · View at Scopus
  63. R. V. Srinivas, R. B. Ray, K. Meyer, and R. Ray, “Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication,” Virus Research, vol. 45, no. 2, pp. 87–92, 1996. View at Publisher · View at Google Scholar · View at Scopus
  64. K. A. Khan, W. Abbas, A. Varin et al., “HIV-1 Nef interacts with HCV core, recruits TRAF2, TRAF5 and TRAF6, and stimulates HIV-1 replication in macrophages,” Journal of Innate Immunity, vol. 5, no. 6, pp. 639–656, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. M. L. Bobbin, J. C. Burnett, and J. J. Rossi, “RNA interference approaches for treatment of HIV-1 infection,” Genome Medicine, vol. 7, no. 1, 2015. View at Publisher · View at Google Scholar
  66. X. Wu, M. Ishaq, J. Hu, and D. Guo, “HCV NS3/4A protein activates HIV-1 transcription from its long terminal repeat,” Virus Research, vol. 135, no. 1, pp. 155–160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. B. Bartosch and J. Dubuisson, “Recent advances in hepatitis C virus cell entry,” Viruses, vol. 2, no. 3, pp. 692–702, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. C. Giannini and C. Bréchot, “Hepatitis C virus biology,” Cell Death and Differentiation, vol. 10, pp. S27–S38, 2003. View at Publisher · View at Google Scholar · View at Scopus